Trial intelligence / Profile preview

NeoRes: Neoadjuvant Radiochemotherapy vs Chemotherapy for Esophageal Cancer

NCT01362127Phase 2Completed

Sponsor
Karolinska University Hospital
Start
Oct 2006
Primary completion
Jun 2013
Modality
Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Cisplatin micelle injection (HA132), fluorouracil in esophageal cancer, gastric cardia cancer (GEJ), sponsored by Karolinska University Hospital. Started Oct 2006; status: completed.

02

Drugs

Cisplatin micelle injection (HA132)fluorouracil
03

Conditions

esophageal cancergastric cardia cancer (GEJ)

Beyond the preview

Go deeper on NCT01362127.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01362127.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call